Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Neuromuscular Disorders : NMD|March 28, 2021
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophyClaudia Brogna, Giorgia Coratti, Rachele Rossi, et al.
JAMA Neurology|August 21, 2023
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical TrialChristine Lebrun-Frénay, Aksel Siva, Maria Pia Sormani, et al.
The Journal of Pediatrics|December 5, 2022
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 BlockadeRoberta Caorsi, Antonella Insalaco, Francesca Bovis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 12, 2020
INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever RegistryRiccardo Papa, Thirusha Lane, Kirsten Minden, et al.
Rheumatology International|May 23, 2018
Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Alessandro Consolaro, Francesca Bovis, Angela Pistorio, et al.
Plos One|February 21, 2018
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patientsLucia Taramasso, Antonio Di Biagio, Francesca Bovis, et al.
Rheumatology International|April 12, 2018
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Alessandro Consolaro, Francesca Bovis, Angela Pistorio, et al.
European Journal of Neurology|March 7, 2023
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar functionMarika Pane, Giorgia Coratti, Valeria A Sansone, et al.
The Lancet. Child & Adolescent Health|March 2, 2019
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort studyAlessandro Consolaro, Gabriella Giancane, Alessandra Alongi, et al.
CNS Drugs|May 29, 2025
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational StudyGiovanni Novi, Francesca Bovis, Chiara Sciolla, et al.
Pageof 19